A. Khan et al., EFFECTS OF LOW-DOSE TRH ON COGNITIVE DEFICITS IN THE ECT POSTICTAL STATE, The American journal of psychiatry, 151(11), 1994, pp. 1694-1696
A low dose (0.5 mg) of thyrotropin-releasing hormone (TRH), a short-ac
ting tripeptide with known analeptic properties, was administered to e
ight depressed patients 5 minutes after ECT session 3 or 4 in a double
-blind, placebo-controlled crossover design. After TRH infusion the pa
tients displayed selectively better performance on a battery of neurop
sychological tests than they did after placebo infusion. Further explo
ration with pharmacological probes to mitigate ECT postictal cognitive
deficits is warranted.